National Equity Fund Names New General Counsel
Michael G. Rogers Joins Leading National LIHTC Syndicator
CHICAGO, Nov. 2, 2015 /PRNewswire-USNewswire/ -- National Equity Fund, Inc. has named Michael G. Rogers as its new general counsel. Rogers returns to NEF after leaving in 2007 having served as associate general counsel for four years.
Most recently, Rogers worked as senior counsel with Holland & Knight LLP representing investors and syndicators in Low Income Housing Tax Credit (LIHTC) and New Markets Tax Credit transactions. Prior to that, he was a staff attorney with Sidley Austin LLP, also working on LIHTC deals. He held positions at Brent Kugman & Associates, FINOVA Capital Corporation, Federal Deposit Insurance Corporation and Greenberger, Krauss & Jacobs, Charted, all providing him with 28 years of experience as an attorney and more than 12 years with affordable housing programs.
"We are excited to have Mike rejoin the team," commented Joseph S. Hagan, president and CEO. "His extensive background in LIHTC deals as well as his knowledge of how a syndicator works will serve our partners well."
Rogers obtained his law degree from Indiana University School of Law and a bachelor's degree in political science from Indiana University
About National Equity Fund, Inc.National Equity Fund, Inc. is a leading syndicator of Low Income Housing Tax Credits. The Chicago-based non-profit is an affiliate of the Local Initiatives Support Corporation and has played an integral role in creating affordable housing options, revitalizing communities and strengthening local economies for more than 27 years. It has invested $11.4 billion in 2,300 LIHTC developments, creating approximately 140,000 affordable homes for low-income families and individuals. For more information, visit www.nefinc.org/
Contact: Maureen Mullady312.697.6460[email protected]
Photo - http://photos.prnewswire.com/prnh/20151102/282944
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/national-equity-fund-names-new-general-counsel-300170558.html
SOURCE National Equity Fund
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Xencor Presents Phase 1 Dose Selection Data for XmAb819, a Potential First-in-Class ENPP3 x CD3 Bispecific T-Cell Engager, in Development for Patients With Advanced Clear Cell Renal Cell Carcinoma and
- Johnson & Johnson reports 75% tumor response rate in advanced prostate cancer with JNJ-6143, a first-in-class RIPTAC™ molecule
- Dogecoin Price Prediction: New Dogecoin Labs Could Lift DOGE From $0.08, but Pepeto Looks Like Early DOGE
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
FDICSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share